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Abstract
Robot-assisted kidney transplantation (RAKT) has recently been introduced to 
reduce the morbidity of open kidney transplantation (KT). Robot-assisted surgery 
has been able to overcome many of the limitations of classical laparoscopy, certainly 
in complex and technically demanding procedures, such as vascular and ureteral 
anastomosis. Since the first RAKT in 2010, this technique has been standardized 
and evaluated in highly experienced robot and KT centers around the world. In 
Europe, the European Association of Urology Robotic Urology Section (ERUS) cre-
ated an RAKT working group in 2016 in order to prospectively follow the outcomes 
of RAKT. When performed by surgeons with both robotic and KT experience, 
RAKT has been proven to be safe and reproducible in selected cases and yield excel-
lent graft function with a low complication rate. Multiple institutions have now 
adopted RAKT, and its use will likely increase in the near future. However, struc-
tured training and proctoring will be mandatory for those embarking on RAKT in 
order to help them negotiate the learning curve and avoid technical mistakes. This 
chapter will describe RAKT from living and deceased donors and its application in 
kidney autotransplantation (KAT).
Keywords: kidney transplantation, living donor, deceased donor, 
autotransplantation, robot-assisted kidney transplantation, robot-assisted kidney 
autotransplantation, robot-assisted, robotic
1. Introduction
Kidney transplantation (KT) is considered the preferred treatment for patients 
with end-stage renal disease (ESRD) owing to the greater survival rate and bet-
ter quality of life in comparison to hemodialysis [1]. To date, the open approach 
has been the gold standard in KT, despite its invasiveness and high morbidity. 
Minimally invasive surgery may be a good alternative to reduce the morbidity 
associated with the open approach, especially in immunocompromised and fragile 
KT patients and even more in obese recipients who are known to have a higher 
complication rate.
Minimally invasive surgery (using a pure laparoscopic or a robot-assisted 
approach) offers significant benefits to patients compared to open surgery, includ-
ing improved peri- and postoperative outcomes, such as shorter hospital stay, less 
Medical Robotics - New Achievements
2
postoperative pain, shorter convalescence period, fewer wound infections, and 
better cosmetic results [2]. Robot-assisted surgery has been able to overcome many 
of the limitations of classical laparoscopy, especially in complex and technically 
demanding surgical procedures, such as reconstruction or vascular and ureteral 
anastomosis. This has been attributed to the superb three-dimensional vision, mag-
nification (12×), control of the camera by the surgeon, elimination of hand tremor, 
and seven degrees of freedom of movement [3].
This chapter will describe the history, technique and results of robot-assisted 
kidney transplantation (RAKT) from living donors and deceased donors, and also 
its application in kidney autotransplantation (KAT).
2. Robot-assisted kidney transplantation (RAKT): living donor
2.1 History and background
2.1.1 Living donor nephrectomy
Open donor nephrectomies were carried out for nearly 50 years until the 
introduction of laparoscopy in 1995 by Ratner et al. [4]. Since its first description 
in 1995, the laparoscopic approach for donor nephrectomy has demonstrated to 
improve peri- and postoperative outcomes such as blood loss, pain, hospital stay, 
as well as cosmetic results, when compared to open surgery. In 2001, the first 
series of robot-assisted laparoscopic donor nephrectomy, using the da Vinci® 
Surgical System (Intuitive Surgical, Sunnyvale, CA, USA), was reported by 
the Group of the University of Illinois (Chicago) [5]. They demonstrated that 
robot-assisted nephrectomy is feasible, safe, and reproducible, providing similar 
results in comparison to the laparoscopic approach [6, 7]. Nowadays, around 
40% of all KT in the USA and around 20% of all KT in Europe are performed 
with living donors. Every year, the ratio of “emotionally related” living donors 
to genetically related living donors increases slightly, with most of the liv-
ing donors currently being family members [8]. In comparison with KT from 
deceased donors, KT from living donors provides several advantages in terms 
of long-term patient survival, earlier graft function, longer graft survival, less 
aggressive immunosuppressive regimens, and reduced waiting lists [9]. When a 
living donor has two equally functioning kidneys, the left kidney is preferred for 
donation as the left renal vein is longer compared to the right renal vein. When 
the kidney function of both kidneys is different, the lesser functioning kidney is 
used for donation, in order to limit the risks for the donor. Many concerns have 
been raised regarding the use of the right kidney for living donation, but litera-
ture suggests that right laparoscopic donor nephrectomy is feasible and results in 
good graft function [10, 11].
2.1.2 Living donor kidney transplantation
RAKT has recently been introduced to reduce the morbidity of open KT. Since 
the first RAKT in 2010 by Giulianotti et al. [12] in the USA, this technique has 
been standardized and evaluated in highly experienced robot and KT centers 
around the world. In 2014 Menon et al. [13] standardized the technique with 
the transperitoneal approach and regional hypothermia known as the Vattikuti-
Medanta technique. The authors highlighted that RAKT is a safe technique with 
possible advantages such as low intra- and postoperative complications, better 
cosmetic results, and superlative vision that could result in better quality of the 
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vascular and ureteral anastomoses. The first two European pure RAKTs were 
performed in July 2015 by Breda et al. [14] and Doumerc et al. [15]. In 2016, 
the European Association of Urology (EAU) formed the EAU Robotic Urology 
Section (ERUS) RAKT working group in order to prospectively follow the 
outcomes of RAKT. Breda et al. [16] published the largest multicenter series of 
RAKT to date (120 patients). Angelo Territo et al. [17] addressed the functional 
results of RAKT from living donors at 1-year follow-up, and Vignolini et al. [18] 
developed a RAKT program with grafts from deceased donors. Siena et al. [19] 
described the technique for RAKT in grafts with multiple vessels. The feasibility 
of RAKT in children was described by the Ghent University group by Spinoit 
et al. [20].
2.2 Operative technique
2.2.1 Living donor nephrectomy
To date, several techniques are described for living donor nephrectomy, includ-
ing open surgery, pure laparoscopy, hand-assisted laparoscopy, and robot-assisted 
surgery [21–23]. The most commonly used technique is the minimally invasive 
transperitoneal laparoscopic approach. According to the literature, laparoscopic 
surgery for living donor nephrectomy achieves similar functional results com-
pared to open and robot-assisted living donor nephrectomy, being equally safe 
for the donor. Robot-assisted surgery offers clear advantages over conventional 
laparoscopy, thanks to the use of EndoWrist instruments, three-dimensional 
view, enhanced visualization of the operative field (12x), and, possibly, a shorter 
learning curve [21, 24]. Open nephrectomy for donation may offer an advantage 
in challenging cases such as grafts with multiple vessels and/or vascular anomalies 
and prior abdominal surgery. Furthermore, the open approach may be preferred in 
centers with low experience in laparoscopy and/or a low case volume of living donor 
nephrectomies [25] (Figure 1).
2.2.2 Back table preparation
After robot-assisted/laparoscopic living donor nephrectomy, the preparation of 
the kidney is performed at the back table close to the operating bed. First, the graft 
is placed in a basin with slushed ice and perfused with 1 liter of storage solution 
(Celsior®, or Custodiol®, or Institut Georges Lopez-1®). Next, the graft vessels 
Figure 1. 
Trocar placement and patient positioning for nephrectomy during RAKT on living donors. (A) 
Laparoscopically: patient positioned in lateral decubitus, linear port configuration along the pararectal 
line, with the camera placed at the most cephalic position (at the 12th rib level). (B) Robot-assisted: patient 
positioned in lateral decubitus; GelPOINT® device at the level of the ipsilateral fossa through a 6 cm 
Pfannenstiel incision; a 15-mm AirSeal trocar is placed in the device to introduce endovascular stapler and the 
15-mm EndoCatch bag for organ extraction. An additional trocar is used to raise the kidney during the section 
of the vessels.
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are carefully dissected. If the donor kidney has multiple arteries or veins, a vascular 
reconstruction can be performed. Siena et al. [19] demonstrated that RAKT is 
possible using grafts with multiple vessels. The ureter can be pre-stented with a 
double-J if preferred. Subsequently, the kidney is wrapped in a gauze filled with 
slushed ice, with the artery and vein brought out through an opening in the gauze 
(Figure 2). The aim is to keep the donor kidney at a constant low temperature after 
insertion in the abdominal cavity, until the vascular anastomoses are finished, and 
the kidney is reperfused. In addition, the gauze can prevent potential graft injury 
from manipulation with the robot arms. To keep the graft temperature below 20°C 
intracorporeally, ice is added through the GelPOINT® (Applied Medical, Rancho 
Santa Margarita, CA, USA) every 15 min.
2.2.3 Robot-assisted living donor kidney transplantation
2.2.3.1 Patient and trocar positioning
When using the da Vinci Si® or X® system, the patient is positioned in 
lithotomy position according to the Vattikuti-Medanta technique [26]. When the 
da Vinci Xi® system is used, the patient is positioned in dorsal decubitus. A 20–30° 
Trendelenburg position is recommended. The required robotic instruments are 
monopolar scissors, Potts scissors, bipolar forceps, prograsp forceps, large needle 
driver, black diamond micro-forceps, and bulldog clamps. A 12 mm camera port is 
inserted in the supra-umbilical area, and a pneumoperitoneum is created. Veress 
needle puncture, optical trocar access, or the Hasson technique can also be used for 
access to the abdomen and creation of a pneumoperitoneum. The open approach 
(Hasson technique) has been reported to result in fewer complications [27]. 
Three extra robotic 8 mm ports are placed under vision, and the robot is docked. 
Figure 2. 
Preparation of the kidney graft after nephrectomy during RAKT from living donors. (A) Ureteral double J 
stent is placed in the graft. (B) A central hole in the gauze from which the artery and vein are outside. (C and 
D) The graft is wrapped in a gauze jacket filled with ice slush.
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Minimal changes in port placement are related according to the robotic system used 
(Figure 3). A GelPOINT® device replaces the camera trocar through a 6–8 cm (four 
fingers) periumbilical incision (Figure 4) once the transplant bed preparation has 
been performed. Alternatively, the GelPOINT® device can be introduced from the 
beginning through a 6–8 cm periumbilical incision, containing the camera and an 
assistant port. This GelPOINT® device is used to introduce the graft in the abdomi-
nal cavity (Figure 4) and allows for insertion of slushed ice (± 200 ml) via modified 
Toomey syringes into the abdominal cavity, surrounding the graft surface with the 
intent to achieve regional hypothermia (i.e., low constant temperature (<20°C) of 
the graft). Additionally, GelPOINT® is a useful device for fast hand introduction if 
needed (i.e., in case of massive bleeding). In selected cases, the graft can be intro-
duced transvaginal as described by few authors [15]. The AirSeal® (Conmed, Utica, 
NY, USA) system might be used in order to maintain a stable and low-pressure 
pneumoperitoneum at 8 mmHg.
2.2.3.2 Transplant bed preparation
Accurate dissection of the external iliac vessels is performed. Subsequently, 
the bladder is prepared for ureteral reimplantation. A retroperitoneal pouch is 
created by incision of the peritoneum following a transverse line above the level of 
the appendix and mobilization of the peritoneal flaps. These will be used to cover 
(retroperitonealize) the graft once the vascular anastomosis is completed. Although 
RAKT is a transperitoneal approach, retroperitonealization of the kidney is per-
formed to avoid pedicle torsion and to enable future graft biopsies.
2.2.3.3 Venous and arterial anastomosis
After clamping of the external iliac vein with robotic bulldog clamps and the 
distal clamp followed by the proximal clamp, a longitudinal venotomy using 
cold scissors is performed. An end-to-side anastomosis between the graft renal 
vein and the external iliac vein is created, using a 6/0 Gore-Tex® CV-6 TTc-9 or 
THc-12 needle (W.L. Gore and Associates Inc., Flagstaff, AZ, USA) continuous 
suture. At the proximal angle, the suture is tied to secure the posterior wall of the 
anastomosis watertight and to avoid stenosis, and then the continuous suture is 
completed until the distal angle. Prior to finishing the anastomosis, the lumen is 
flushed with heparinized solution using a 4.8 Fr ureteric catheter. The catheter 
may be pulled out by the assistant from outside the abdomen while the surgeon 
Figure 3. 
Trocar placement and patient positioning for RAKT for Si/X/Xi in the right iliac fossa. Patient repositioned 
in dorsal decubitus, legs in Allen stirrups, table in 20–30° Trendelenburg; GelPOINT® device at the level 
of the umbilicus through a 6–8 cm vertical peri-umbilical incision; camera trocar and ice applicator in the 
GelPOINT® (eventually with 12 mm AirSeal® port); 3–8 mm robotic trocars in the lower abdomen, 2 in the 
left fossa and 1 in the right iliac fossa.
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tightens the knot to secure the anastomosis (Figure 5). Next, the graft vein is 
clamped, and the bulldog clamps are removed from the external iliac vein and 
positioned on the external iliac artery, first proximally and then distally. The 
artery may be incised with the cold scissors or a scalpel at the 1–2 o’clock position. 
Arteriotomy may be completed using a laparoscopic aortic punch to transform 
the linear arteriotomy into a circular one. In both arterial and venous anastomo-
sis, the anastomosis is started by passing the needle in the external iliac vessel 
in an outside-inside direction and then inside-outside through the graft vessel 
(Figure 6). For the venous anastomosis, the knot is tied now, and the needle is 
then passed outside-inside through the renal vein to start the running suture. For 
the arterial anastomosis, the suture is not tied yet (as for the venous anastomo-
sis), and the needle is passed through the graft artery outside-inside before tying 
the suture to a loop that is left outside. This is done to prevent a difficult first 
needle passing in a small arterial lumen. After completing the arterial anasto-
mosis, a clamp is positioned on the graft artery while the external iliac artery is 
declamped. If no sign of leakage (bleeding) is observed, the graft vein and artery 
are declamped. The evaluation of the graft perfusion is primarily visual: pink 
colorization, a pulsatile graft artery, filling of the renal vein, and small bleedings 
from the renal capsule and urine output are signs of perfusion. Doppler ultra-
sound evaluation (drop-in ultrasound probe linked to TilePro™ function of the 
da Vinci Surgical System) is recommended to verify adequate perfusion of the 
graft.
2.2.3.4 Ureteroneocystostomy
After flipping the kidney on the psoas and retroperitonealization of the graft, 
the ureteroneocystostomy is performed according to the Lich-Gregoire technique 
using a Monocryl or PDS 5/0 (Ethicon Inc., Cincinnati, OH, USA) continuous 
Figure 4. 
Introduction of the kidney and ice through the Gel-POINT®. (A) The GelPOINT® device is placed through 
a 6 cm (four fingers) incision. (B) Ice slush is introduced in the abdominal cavity using modified Toomey 
syringes. (C and D) The graft is introduced into the abdominal cavity. (E and F) Once the graft is inside, 
Gel-POINT® cup is inserted to close the abdomen.
7Robot-Assisted Kidney Transplantation
DOI: http://dx.doi.org/10.5772/intechopen.90276
suture (Figure 7). Care is taken to construct an adequate detrusor tunnel as anti-
reflux mechanism. A double-J stent is inserted to protect the anastomosis. The stent 
can be removed after 3 weeks.
Figure 5. 
Overview of the main steps for venous anastomosis during RAKT from living donors. (A) The graft renal vein 
is anastomosed in an end-to-side continuous fashion to the external iliac vein using a 6/0 Gore-Tex®. (B and 
C) At cranial angle, the suture is knotted to fix the posterior wall of the anastomosis. (D and E) The running 
suture is completed at the caudal angle. (F) Before completing the anastomosis, the lumen is flushed with 
heparinized solution using a 4.8 Fr ureteral catheter.
Figure 6. 
Overview of the main steps for arterial anastomosis during RAKT from living donors. (A) The robotic scalpel 
is used to make a linear incision on the iliac artery, converting it in circular hole with a laparoscopic vascular 
punch. (B) The running suture is carried out using a 6/0 Gore-Tex®; particularly in the caudal tying of an 
arterial anastomosis, the needle is passed in the external iliac vessel in an outside-inside direction, then outside-
inside through the graft vessel. (C and D) The running suture is completed at the caudal angle.
Medical Robotics - New Achievements
8
2.3 Results
After reporting a single center experience on 17 cases of RAKT from living dona-
tion [28], the European Experience in RAKT was published in 2018. One hundred 
twenty cases were prospectively collected in eight centers across Europe [16]. The 
authors demonstrated the low complication rate (at 1 month follow-up) while 
maintaining excellent graft function (median eGFR at 30 days was 58 ml/min) and 
cosmetic results (Figure 8). Three cases of graft loss due to arterial thrombosis dur-
ing the first postoperative week were reported in these series (2.5%). This complica-
tion might be associated with technical errors during the learning curve. Territo 
et al. [17] demonstrated that the functional results at 1-year follow-up were not 
statistically different from the functional results at 1-month follow-up. The compli-
cation rate remained low. To date, there are no studies available comparing RAKT 
with the conventional open approach. However, an increasing body of evidence 
confirms that RAKT is at least non-inferior to open KT regarding both patient and 
graft survival [16, 29].
3. Robot-assisted kidney transplantation (RAKT): deceased donor
3.1 Background
The vast majority of RAKT worldwide has been performed from living donors, 
raising concerns regarding the generalizability of RAKT outcomes in the broader 
and more challenging scenario of deceased donors.
While it has been shown that the learning curve for elective RAKT (i.e., liv-
ing donor RAKT) may be minimal for surgeons with extensive experience in 
robotic surgery (regardless of their background in open KT) [30, 31], RAKT 
Figure 7. 
Ureteroneocystostomy performed according to the Lich-Gregoir technique. In (A) and (B) running suture 
between ureteral and bladder mucosa using 5-0 Monocryl. In (C) and (D) the details of the anti-reflux tunnel.
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from deceased donors has unique technical and logistical challenges. Indeed, due 
to the timeframe of organ preservation, it can be considered an unforeseeable 
“emergency” robotic procedure, which requires a structured multidisciplinary 
framework.
3.2 Development of a structured RAKT program from deceased donors
To fill this gap and move the field forward, the University of Florence group has 
recently developed a RAKT program from deceased donors aiming to safely and 
progressively increase the pool of patients who may benefit from minimally inva-
sive KT [18].
The cornerstones of this program are as follows: (a) an extensive experience in 
open KT (n > 1100 KTs from 1991) and robotic urologic surgery (>4000 procedures 
from 2010, including radical prostatectomy, radical nephrectomy, partial nephrec-
tomy, radical cystectomy, dismembered pyeloplasty, and ureteral reconstructive 
surgery); (b) a codified technique for RAKT [13, 16]; (c) a structured modular 
training in RAKT, including e-learning, simulation, and dry lab and wet lab training 
on animal models [32]; (d) the availability of a multidisciplinary team (composed 
by urologists, anesthesiologists, nephrologists, radiologists, as well as operating 
room support staff and nurses) with experience in KT and robotic surgery; and 
(e) the opportunity to perform RAKT at nighttime and/or during the weekend in a 
dedicated operating room [18].
3.3 Selection criteria for RAKT from deceased donors
Following the University of Florence, recipient’s exclusion criteria for RAKT 
from deceased donors include the following: (a) age < 18 years; (b) severe 
comorbidities with contraindication for robotic surgery; (c) significant athero-
sclerotic plaques at the level of external iliac vessels; (d) highly complex vascular 
graft anatomy (likely to require multiple anastomoses); (e) multiple previous 
abdominal surgeries; and (f) previous KT. A key element of the RAKT program 
Figure 8. 
Esthetic results of RAKT 3 months later.
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from deceased donor is also represented by the decision-making process aim-
ing to assess the feasibility of RAKT in light of the patient-, graft-, and robotic 
team-related factors [18] (Figure 9). As such, the decision to proceed with an 
“emergency” RAKT from a deceased donor relies on a careful balance of the 
potential advantages of robotic surgery (for both the patient and the surgeon) 
and the logistical challenges of setting up the operating room and the robotic 
surgical team in a fixed timeframe, respecting the recipient’s selection criteria 
and the maximal thresholds of cold ischemia time. Specifically, planning RAKT 
from deceased donors follows a pre-specified decision-making process. First, 
after the alert of a kidney offer is addressed to our transplant team by the Regional 
Allocation Centre, the surgeon in charge considers the opportunity to perform 
RAKT according to his/her personal experience and the availability of an expert 
bedside assistant as well as an expert robotic operating room nursing staff. Then, 
after the recipient is admitted to the nephrology unit for the pretransplant clinical 
work-up (which systematically includes a computed tomography angiogram of the 
abdomen to check for severe atherosclerotic plaques at the external iliac vessels), 
the surgeon checks that the recipient’s inclusion criteria are met. Subsequently, 
the robotic operating room is checked for availability (even during weekends, at 
nighttime, and potentially during daytime, if elective non-oncologic robotic pro-
cedures can be safely rescheduled), ensuring that the bench surgery starts within 
16 hours from the beginning of cold storage of the kidney. Finally, at the time 
of bench surgery, the graft is carefully inspected to ensure no exclusion criteria 
for RAKT is present (i.e., highly complex vascular anatomy requiring multiple 
vascular anastomoses).
3.4 The University of Florence technique for RAKT from deceased donors
A step-by-step overview of our surgical technique for RAKT from deceased 
donors is shown in Figures 10–12.
Figure 9. 




All procedures were performed with the da Vinci Si® or Xi® robotic platform in 
a four-arm configuration with a zero-degree lens and one assistant port [18], by a 
single surgeon (G.V.) with extensive experience in robotic urologic surgery and open 
KT. The pneumoperitoneum pressure was set at 8 mm using the AirSeal® system, 
while the Trendelenburg was tilted at 20° in all cases.
The robotic instruments employed for RAKT included the following: (a) large 
needle driver; (b) black diamond micro-forceps; (c) monopolar curved scissors; 
(d) Maryland bipolar forceps; (e) prograsp forceps; and (f) robotic bulldog clamps. 
Laparoscopic instruments included a needle driver, the suction device, laparoscopic 
scissors, Hem-o-lok (Weck Surgical Instruments, Teleflex Medical, Durham, NC) 
clips and clip applier, Johan grasping forceps, and the drop-in ultrasound probe.
For insertion of the graft inside the abdominal cavity [13, 16], we employ the 
GelPOINT® or the Alexis® wound retractor (Applied Medical, Rancho Santa 
Margarita, CA) through a Pfannenstiel incision (Figure 10). Regional hypothermia 
is achieved by cooling the graft with ice slush introduced through the GelPOINT® 
via modified Toomey syringes, as previously described [13, 16].
Intraoperative indocyanine green (ICG) fluorescence videography (IFV) (i.e., 
FireFly® technology) is used to assess the graft and ureteral reperfusion [33, 34].
Abdominal organ procurement is performed according to established prin-
ciples for donors after brain death (DBD) [35], while specific protocols were 
followed in the case of donors after circulatory death (DCD) [36]. In this setting, 
the kidneys are preserved in a hypothermic machine perfusion device (LifePort 
Kidney Transporter® (Organ Recovery Systems Inc. Chicago, USA)) before 
transplantation.
During bench surgery (Figure 10), the graft is perfused with Celsior® solution 
and inserted in a gauze jacket filled with ice (and closed with 4–5 stiches) after 
placement of a 6F, 14 cm double-J stent. Two landmark stiches are placed on the 
upper and lower sides of the graft vein, while one landmark stich is placed on the 
upper side of the graft artery, to facilitate the subsequent orientation of the graft 
inside the abdominal cavity. Finally, the graft artery is modeled to facilitate subse-
quent intracorporeal arterial anastomosis.
Figure 10. 
Overview of the main steps for bench surgery (A-E), port placement (F-H) and insertion of the graft into the 
abdominal cavity (I, J) during RAKT from deceased donors.
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Figure 11. 
Overview of the main steps for venous anastomosis during RAKT from deceased donors. (A) A 1–2 cm 
venotomy is performed on the external iliac vein. (B) The lumen of the external iliac vein is flushed with 
heparinized saline. (C–F) The graft renal vein is anastomosed in an end-to-side continuous fashion to the 
external iliac vein using a 6/0 Gore-Tex®. (G and H) The running suture is completed at the caudal angle.
RAKT from deceased donors at our Institution follows the principles of the 
Vattikuti-Medanta technique [13], adopted by all other centers included in the 
ERUS-RAKT group [16].
Of note, this technique allows performance of a transperitoneal RAKT with final 
retroperitonealization of the graft after kidney reperfusion.
After induction of general anesthesia, port placement, and docking of the da Vinci 
Si/Xi robotic platform, the iliac vessels are dissected and prepared for subsequent 
anastomoses. Then, an extraperitoneal pouch is created, and access is gained into the 
Retzius space in order to prepare the bladder for subsequent ureteroneocystostomy [18].
Then, a Pfannenstiel incision is performed, and the GelPOINT® device or 
the Alexis® wound retractor is set in place. The graft is subsequently introduced 
into the abdominal cavity and the robot is redocked. After achievement of 
regional hypothermia, a venotomy is performed, the lumen of the external iliac 
Figure 12. 
Overview of the main steps for arterial anastomosis during RAKT from deceased donors. (A-E) A linear 
arteriotomy is performed and converted into a circular arteriotomy with cold scissors. (F-L) The renal artery is 
anastomosed in an end-to-side fashion to the external iliac artery using a 5/0 Gore-Tex suture on a CV-6 TTc-9 




vein is flushed with heparinized saline, and the venous anastomosis is completed 
in an end-to-side fashion using a 6/0 Gore-Tex suture on a CV-6 TTc-9 needle 
(Figure 11). After additional graft cooling, a liner arteriotomy is performed and 
converted into a circular arteriotomy with cold scissors. The renal artery is then 
anastomosed in an end-to-side fashion to the external iliac artery using a 5/0 Gore-
Tex suture on a CV-6 TTc-9 needle with two running sutures (Figure 12).
After the integrity of the anastomoses is tested, the graft is revascularized 
and inspected for color and turgor. Intraoperative Doppler ultrasound with the 
TilePro® feature is employed to check for graft reperfusion in case the da Vinci Si 
robotic platform is used. On the contrary, if the da Vinci Xi® platform is available, 
graft and ureteral reperfusions are assessed using intraoperative indocyanine green 
(ICG) fluorescence videography (IFV) [33]. Then, the graft is allocated in the 
extraperitoneal pouch, which is partially closed by reapproximating the previously 
prepared peritoneal flaps with a V-lock running suture or single Hem-o-lok clips. 
This step avoids graft torsion, facilitates postoperative graft monitoring, and allows 
convenient access for ultrasound-guided transplant renal biopsy and/or placement 
of nephrostomy tubes, if needed [37]. Interestingly, we recorded a laminar perirenal 
fluid collection in almost all patients at ultrasound examinations during the first 
postoperative period (i.e., postoperative days 1 and 7 and at hospital discharge). 
However, subsequent follow-up evaluations showed a progressive reduction of 
this fluid collection until complete reabsorption within 20–30 days after surgery, 
confirming the complete retroperitonealization of the graft [37].
The last step of the procedure is the ureterovesical anastomosis, which is per-
formed according to a modified Lich-Gregoire technique over the double-J stent. 
The ureter is anastomosed to the bladder mucosa with two 4.0 Monocryl running 
sutures; then the detrusor muscle is closed creating an anti-reflux mechanism.
The technique for RAKT from deceased donors evolved over time throughout the 
learning curve [34]. In particular, few technical nuances have been introduced, accord-
ing to the surgeon’s preference and skills, with the aim to improve the esthetic result and 
the cost-effectiveness of RAKT, as well as to optimize critical steps such as the assess-
ment of graft and ureteral reperfusion before ureterovesical anastomosis [38].
These technical modifications include insertion of the graft into the abdominal 
cavity through a Pfannenstiel incision (rather than a periumbilical incision), to 
improve the esthetic result of RAKT and facilitate the positioning of the graft in the 
pelvis close to the iliac vessels.
Second, the placement of the GelPOINT® device is achieved after preparation 
of iliac vessels, bladder, and extraperitoneal pouch, to make sure not to injure the 
bladder while positioning the GelPOINT® device through the Pfannenstiel inci-
sion. Of note, in the case of recipients with autosomal dominant polycystic kidney 
disease (ADPKD), all ports are positioned approximately 3 centimeters downward 
on the same lines to obtain an increased working space in the right iliac fossa far 
from the enlarged polycystic kidneys [38].
While mirroring the Vattikuti-Medanta technique, the steps of venous and arte-
rial anastomoses differ slightly from those originally described by the ERUS-RAKT 
group [18]. In all cases of right-sided grafts, an inferior vena cava (IVC) cuff is used 
during bench surgery to increase the length of the graft renal vein to facilitate the 
subsequent venous anastomosis. However, according to our experience in RAKT 
using right-sided grafts from living donors, the use of an IVC cuff does not appear 
to be mandatory, as the robotic platform facilitates the performance of a tension-
free venous anastomosis even in case of short renal veins.
The venotomy is performed using the standard curved scissors (rather than the 
Potts scissors), and the venous anastomosis is completed in a two-step fashion: first, 
the posterior plate is closed using a running suture from 12 to 6 o’clock position; 
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then, a knot is tied, and the anterior plate is completed with a second running 
suture with the same thread from 6 to 12 o’clock position (Figure 11). Tying the 
knot at 6 o’clock position after completion of the posterior plate may be key to 
reduce the tension on the anterior plate of the anastomosis, tailoring it according to 
the graft vein shape and length.
Similarly, the technique for arterial anastomosis follows the principles of the 
Vattikuti-Medanta technique [13, 16] with key technical nuances in case of deceased 
donors. First, the arteriotomy is achieved using standard cold scissors (rather than 
using the aortic punch). Second, due to the increased risk of atherosclerotic plaques 
and/or calcifications at the level of the external iliac arteries, the arterial anastomo-
sis is performed using two different threads (Figure 12). First, the posterior plate 
of the anastomosis is closed using a running suture from 12 to 6 o’clock position, 
without tying a knot at 6 o’clock position. Then, the anterior plate is closed in a 
similar fashion with a running suture from 12 to 6 o’clock position using a second 
thread. Finally, the two free ends of the threads are tied together at 6 o’clock posi-
tion, after checking the integrity of the anastomosis. This technique allows to tailor 
the tension of the anastomosis according to the stiffness and characteristics of both 
the renal and iliac vessels.
Third, the arterial anastomosis during RAKT from deceased donors is per-
formed using a slightly thicker thread (Gore-Tex 5/0 instead of 6/0).
A specific challenge in case of RAKT from deceased donors is represented by the 
management of the Carrel’s patch for arterial anastomosis. At the beginning of our 
robotic program for deceased donor RAKT [18], after careful bench surgery show-
ing no significant atherosclerotic plaques at the level of the renal artery ostium, 
we performed the anastomosis using the Carrel’s patch (Figure 12). However, with 
increasing experience the anastomosis is increasingly being performed without the 
Carrel’s patch. While in few cases at the beginning of the program, the surgeon had 
to remove the patch due to the presence of significant atherosclerotic plaques, in the 
following cases, the Carrel’s patch was removed intentionally during bench surgery, 
and the anastomosis was performed mirroring the technique adopted for living 
donor RAKT. From a technical point of view, and thanks to the robotic platform, 
removing the Carrel’s patch may provide significant advantages for the surgeon. 
These include (a) the opportunity to perform a shorter arteriotomy; (b) a more 
anatomic anastomosis, thanks to the similar caliber of the graft renal artery and 
external iliac artery; and (c) the reduced risk of atherosclerotic plaques at the level 
of the graft renal artery (as compared to Carrel’s aortic patch).
Finally, a specific technical modification proposed by our group for RAKT from 
deceased donors is represented by the use of intraoperative indocyanine green 
(ICG) fluorescence videography (IFV) to assess graft and ureteral reperfusion [33, 
34]. The tips and tricks for the use of this technique during RAKT from deceased 
donors are discussed in the previous publications [18, 33, 34]. In brief, a bolus of 
0.3 mg/kg of ICG dissolved in 5% glucose (2 mg/ml) is administered intravenously 
after completion of vascular anastomoses to allow performance of a real-time quali-
tative and potentially quantitative assessment of graft and ureteral fluorescence 
signal [34]. Forty seconds after ICG injection, the camera is switched to reveal 
fluorescence at the level of vascular anastomoses and the renal parenchyma and 
ureter to check for their reperfusion, allowing to adapt the ureteral length according 
to the fluorescence signal to reduce the chance of postoperative ureteral strictures.
3.5 RAKT from deceased donors: preliminary results
Overall, 32 RAKTs have been performed at the University of Florence from 




The first RAKT from a deceased donor was performed in August 2017. Of the 32 
RAKT performed so far, 19 (59.4%) were from deceased donors (n = 5 [26%] from 
DCD donors; n = 14 [74%] from DBD donors).
Interestingly, thanks to the structured RAKT program developed at the 
University of Florence, the proportion of RAKT increased over time in the last 3 
years, being 18.3%, 26.4%, and 24% of all KT in 2017, 2018, and 2019, respectively. 
Similarly, the proportion of RAKT from deceased donors increased over time, being 
11.1% in 2017, 19.6% in 2018, and 14.3% in 2019 of all KT from deceased donors.
The University of Florence group very recently published their results on their 
first 17 RAKTs from deceased donors [18]. They now performed 19 cases, all suc-
cessfully completed without need of open conversion.
The da Vinci Si and Xi robotic platform was used in 15 (79%) and 4 (21%) cases, 
respectively. In the vast majority of cases (n = 17), RAKT was performed in the right 
iliac fossa.
The graft was introduced using the GelPOINT® device (or the Alexis® port) 
in 14 (73.7%) cases through a Pfannenstiel incision, while in 5 (26.3%) through a 
periumbilical incision.
They recorded one case of intraoperative complication (intraoperative bleeding 
not requiring transfusion) that required positioning of an additional 5 mm port to 
increase exposure and help aspiration. Three patients (16%) suffered a high-grade 
(Clavien-Dindo grade 3) complication (transplant renal artery stenosis requiring 
percutaneous angioplasty in one patient; percutaneous placement of a nephrostomy 
tube for hydronephrosis in one patient and transplant renal artery thrombosis 
requiring graft nephrectomy).
A progressive improvement of renal function was recorded at all time points 
during the postoperative period. Median eGFR at hospital discharge (median 
12 days post-op) was 47.2 ml/min/1.73m2 (IQR 28.9–59.4), while median eGFR at a 
median follow-up of 15 months was 58.6 ml/min/1.73m2 (IQR 40.0–80.4).
Overall, five (26%) patients required dialysis during the first postoperative 
week. Of these, one patient due to primary nonfunction after RAKT from an 
uncontrolled DCD donor; one patient due to graft nephrectomy due to arterial 
thrombosis; one patient for suspected acute rejection treated with intravenous 
corticosteroids; and two patients for DGF.
At a median follow-up of 15 months, all patients are alive, and two patients are 
still on dialysis.
3.6 RAKT from deceased donors: future perspectives
We developed the first structured program of RAKT from deceased donors 
worldwide.
Despite being preliminary, our experience confirms the feasibility of RAKT in 
this donation setting in centers with a solid background in open KT and robotic 
surgery and after proper standardized modular training.
From a logistical perspective, RAKT from deceased donors poses specific 
challenges, which require a comprehensive, multidisciplinary effort to redesign 
the management strategy of the institution’s transplantation pathway. In this view, 
a highly trained and committed surgical team, as well as the opportunity of a 
dedicated flexible robotic operating room, are key elements for the success of the 
program.
The perioperative and functional data in our preliminary series are promising 
but warrant further investigation. In particular, larger studies with longer follow-
up are needed to confirm the safety of RAKT from deceased donors (especially 
DCD donors), to evaluate the impact of learning curve on patient outcomes, and to 
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identify the predictors of adverse perioperative events (i.e., major surgical compli-
cations, PNF and DGF) to refine patient selection.
Yet, extending the number of robotic transplantations performed by centers 
experienced in robotic surgery using grafts from deceased donors would be key 
to increase the pool of patients who may benefit from minimally invasive surgery. 
Notably, this is a critical step toward the definition of evidence-based indications 
for RAKT in this clinical scenario also from a Guideline’s perspective [39].
We entirely share Dr. Alcaraz and colleagues’ perspective that “although major 
improvements in outcomes for transplant patients are likely to come from the field 
of immunology, small, measurable improvements may yet be possible via techni-
cal advances” [40]. As such, we believe RAKT, which is likely to be increasingly 
performed by referral transplant centers worldwide, may provide unique opportu-
nities for both patients and surgeons, allowing to improve the precision and reduce 
the morbidity of this procedure. To move the field forward, implementing RAKT 
programs from deceased donors is the most compelling clinical unmet need for the 
transplant and urological community.
4. Robot-assisted kidney autotransplantation (RAKAT)
4.1 History and background
In 1902 Ullmann [41] and Carrel [42] experimentally achieved the first success-
ful animal kidney autotransplantation (KAT), moving the kidney of a dog from its 
lumbar fossa to its neck, in this way laying the foundations for future kidney (auto)
transplantation. In 1956, the Brazilian Campos Freire [43] attempted KAT for the 
first time on a man with a renal artery aneurysm, although an early thrombosis 
forced him to perform a nephrectomy. In 1961, Shackman and Dempster repeated 
this in a case of unilateral renal artery stenosis but with unsatisfactory results [44]. 
It was not until 1963 when JD Hardy et al. achieved the first successful KAT in 
human in a case of high ureteral stricture after a large aortic aneurysm repair [45]. 
McLaughlin et al. demonstrated its utility in the management of complex renal 
lesions. Following these pioneering surgeries, KAT was adopted as a method to 
perform renal artery angioplasty in treating hypertension caused by severe renal 
artery stenoses. In these vascular cases, the ureter was usually not transected; the 
vascular pedicle is reconstructed in or close to the abdominal incision with sub-
sequent vascular reimplantation on the iliac vessels, making this actually a renal 
transposition. Only when the indication concerns primary ureteral pathology or 
when the kidney needs complex surgery on the bench table (and both the vascular 
pedicle and the ureter are sectioned and subsequently reimplanted), the term KAT 
is correct. Nowadays, most renovascular problems are treated with endovascular 
methods, and the indications for KAT have been shifted more toward managing 
complex ureteral strictures or malignant pathologies for which endoluminal or 
in vivo repair is impossible or contraindicated. Less frequent indications include 
loin pain hematuria syndrome, retroperitoneal fibrosis, and metabolic stone 
disease [46].
KAT is an important surgical last resort technique in order to spare the kidney in 
select cases. It allows ex vivo management of complex renal or ureteral pathology, 
which would not be treatable with conventional techniques, without resulting in 
important kidney function loss. For this purpose, the harvested kidney is cooled on 
ice slush and flushed with an ice-cold preservation solution during bench surgery, 




Traditionally, KAT has been performed through a large midline laparotomy, a 
large paramedian extraperitoneal incision or the combination of a lumbotomy for 
the nephrectomy phase with a lower abdominal incision for the transplantation 
phase; thus being a very invasive procedure, and, albeit having a low mortality 
rate (1.3%), postoperative morbidity may be as high as 46.2%. Due to the historic 
invasiveness of the procedure, and the unfamiliarity of many urologists with the 
field of KT, KAT has never gained much popularity and often these kidneys were 
sacrificed. However, since the introduction of laparoscopy in urology, attempts 
have been made to reduce the morbidity of open KAT. Fabrizio et al. [47] described 
in 2000 the first laparoscopic nephrectomy for KAT; however, the patient still 
required a periumbilical incision for extraction of the graft and a pelvic incision 
for the transplantation [47]. Today, the most accepted approach is to perform 
laparoscopic nephrectomy, via a three-port transperitoneal access, and open KAT, 
using the classical Gibson incision for both extraction and introduction of the 
graft, resulting in possible low complication rate and excellent long-term autograft 
function [48].
In recent years, due to the success of RAKT, interest is rising to reevaluate KAT 
as an ultimate nephron-sparing option in complex cases. In 2014, Gordon et al. pub-
lished the first case of robot-assisted kidney autotransplantation (RAKAT) to treat 
extensive ureteral loss after complicated ureterorenoscopy for ureterolithiasis [49]. 
They used a completely intracorporeal technique, establishing in vivo hypothermic 
renal perfusion by continuous renal artery irrigation. The robot was redocked 
between nephrectomy and transplantation phase, and the table was repositioned 
rather than the patient. The complete intracorporeal technique was successfully 
repeated by Lee et al. [50] in 2015. Despite these promising results, the totally 
intracorporeal technique is not suitable in patients where ex vivo bench repair is 
required (e.g., multiple vessel grafts, complex oncological cases, lithiasis treatment) 
or where the surgeon would prefer to transplant the autograft in the contralateral 
iliac fossa (e.g., disturbed pelvic vascular anatomy or excessive fibrosis). In the 
same period, Sood et al. theoretically described a technique for RAKAT using 
extracorporeal tabletop graft reconstruction, using a GelPOINT device, in order to 
broaden indications of RAKAT [51]. In 2017, Araki et al. [52] published a case using 
this extracorporeal RAKAT technique in a patient with proximal ureteral stenosis. 
Also in 2017, Decaestecker et al. [53] performed the first extracorporeal RAKAT 
in Europe and to date have the largest series of RAKAT worldwide. This European 
series also adopted a totally intracorporeal technique.
4.2 Operative technique
Decaestecker et al. published the largest series of RAKAT worldwide, all for 
non-oncological cases [53]. Their technique is based on the experience within the 
ERUS-RAKT working group, as described by Breda et al. [16], and on the theoreti-
cal report by Sood et al. [51]. We will describe the extracorporeal bench work 
technique and the totally intracorporeal technique with the da Vinci Si® and Xi® 
robotic platform.
4.2.1 Extracorporeal bench work technique (video)
4.2.1.1 Trocar and patient position
Figures 13 and 14 describe the patient and trocar positioning for Si and Xi, right 
or left, during nephrectomy and transplantation phase.
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Figure 14. 
Trocar and patient positioning for extracorporeal RAKAT using Xi. Nephrectomy phase: patient in lateral 
decubitus; GelPOINT® through a 6 cm vertical peri-umbilical incision containing robot and assistant 
trocar; three 8 mm robot trocars in hemiabdomen on a slightly oblique line, 2 subcostal and 1 in the iliac fossa. 
Transplantation phase: patient repositioned in lithotomy position, table in 20–30° Trendelenburg; three 8 mm 
robotic trocars in the lower abdomen, reusing 1 former iliac fossa trocar site. Low-pressure pneumoperitoneum 
realised with the AirSeal®System.
4.2.1.2 “Donor” nephrectomy
A “donor” nephrectomy is performed with the patient in the lateral decubi-
tus position, maximizing the renal vessel length and transecting the ureter just 
Figure 13. 
Trocar and patient positioning for extracorporeal RAKAT using Si. Nephrectomy phase: patient in lateral 
decubitus; GelPOINT® through a 6 cm vertical peri-umbilical incision containing camera and assistant 
trocar; three 8 mm robot trocars in hemiabdomen, one subcostal and 2 in the iliac fossa. Transplantation 
phase: patient repositioned in lithotomy position, legs in Allen stirrups, table in 20–30° Trendelenburg; 
three 8 mm robotic trocars in the lower abdomen, reusing the 2 former iliac fossa trocar sites. Low-pressure 




proximal of the strictured segment or at the level of the crossing with the iliac 
vessels. After administering 2500–5000 units of heparin intravenously according to 
the weight of the patient, the renal vessels are transected after securing the vessels 
with either a laparoscopic/robotic vascular stapler or double clipping the vessels 
with Click’aV plus® clips (Grena, Amsterdam, the Netherlands, Europe), followed 
by a transfixing ligation of the clipped vascular stump with Prolene® 5/0 (Ethicon 
Inc., Johnson & Johnson Corp, Cincinnati, OH, USA) to prevent clip slipping. The 
latter is done robotically after the kidney is exteriorized by the table-side assistant 
through the GelPOINT®.
4.2.1.3 Bench work
Upon retrieval, the graft is immediately perfused on the bench with 4° 
Celsius preservation solution (Institut Georges Lopez-1®). If necessary, bench 
vascular reconstruction can be performed for duplicated renal arteries (end-to-
side reconstruction of the lower pole to main artery or pantaloon reconstruction 
of two central arteries). During cold storage, tabletop flexible ureterorenoscopy 
or nephroscopy can be performed to extract nephro- or ureterolithiasis. The 
kidney is wrapped in an ice gauze jacket with a central hole exposing the renal 
hilum (Figure 15).
4.2.1.4 Transplantation phase
During cold storage, the robot is undocked, the incisions are temporarily closed, 
and the patient is repositioned in lithotomy position (Si/X) or dorsal decubitus 
(Xi). For the transplantation phase, the robot is redocked, and RAKT is performed 
following the Vattikuti-Medanta technique as previously described and adopted 
by the ERUS-RAKT group. With the extracorporeal technique, the kidney is usu-
ally transplanted to the contralateral iliac fossa unless the proximal ureter of the 
graft is absent or very short and urges a ureteropyelostomy (native distal ureter 
to transplant pyelum) or uretero-ureterostomy (native distal ureter to transplant 
ureter). The iliac vessels can be very hard to dissect due to excessive fibrosis caused 
by previous surgery and/or radiotherapy.
Figure 15. 
Bench work in extracorporeal RAKAT technique. (A) End-to-side anastomosis of lower pole artery on main 
renal artery. (B) Extraction of nephrolithiasis. (C) Nephroscopy. (D) Extraction of lithiasis from calyceal 
diverticulum and closing diverticulum infundibulum. (E) Wrapping of the kidney in ice gauze jacket, leaving 
opening for the structures.
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4.2.2 Totally intracorporeal technique
4.2.2.1 Selection of patients
The totally intracorporeal technique is not suitable in patients where ex vivo 
bench repair is required (e.g., multiple vessel grafts, complex oncological cases, 
lithiasis treatment) and might be less optimal in cases where the surgeon would pre-
fer to transplant the autograft in the contralateral iliac fossa (e.g., disturbed pelvic 
vascular anatomy or excessive fibrosis).
4.2.2.2 Trocar and patient position
Figures 16 and 17 describe the patient and trocar positioning for Si and 
Xi, right or left, during nephrectomy and transplantation phase. Note that 
the GelPOINT® device is not used and as much trocars as possible are reused, 
although some need to be exchanged for each other. For the transplantation 
phase, the patient is positioned on the PinkPad® (Kebomed, Apeldoorn, the 
Netherlands, Europe) in a modified lateral flank position using inflatable pressure 
bags. Together with maximal side tilting of the table (15°), the patient is in a 65° 
flank position which makes nephrectomy feasible. After nephrectomy and intra-
corporeal flushing, the robot needs to be undocked, and the table is repositioned 
rather than the patient (from maximal side tilt to contralateral maximal side tilt, 
partially) deflating the pressure bags to bring the patient more or less horizontal 
and adding 20–30° of Trendelenburg). Using the Si/X system, the robot needs to 
Figure 16. 
Trocar and patient positioning for RAKAT intracorporeal technique Si. No use of GelPOINT® device. 
Nephrectomy phase: patient positioned in lateral decubitus; camera trocar supra-umbilical, three 8 mm robot 
trocars in hemiabdomen, AirSeal trocar as assistant trocar infra-umbilical. Transplantation phase: robot 
undocked, table repositioned rather than the patient, and robot redocked (side-docking next to left leg); three 
8 mm robotic trocars in the lower abdomen, reusing 1 former caudal robot trocar site and AirSeal trocar site; 




be repositioned from flank-docking tot side-docking; using the Xi system, only the 
boom needs to be rotated 90° before redocking. In case of expected pelvic fibrosis, 
it is wise to prepare the iliac vessels before clamping the renal hilum in order to 
reduce intracorporeal “cold” ischemia time as well as the amount of intracorporeal 
cold fluid that could potentially lower central body temperature. This means that 
three phases with two repositions are necessary. The Xi system with easy docking 
and repositioning of the boom and integrated table motion is a real advantage for 
these challenging cases.
4.2.2.3 “Donor” nephrectomy
During nephrectomy, more fat is left on the lower pole of the kidney in order 
to be able to manipulate the kidney intracorporeally. Care should also be taken 
to skeletonize the renal vessels and gain adequate length as would normally be 
performed on the bench. After clamping the renal vessels, they are not transected, 
but incised to introduce a 5–7 Fr Fogarty catheter with open tip to flush the kidney 
intracorporeal with 4°C physiologic NaCL solution until the effluent is clear. Note 
that any solution containing potassium should not be used in order to prevent 
hyperkalemia and possible arrhythmias by peritoneal reabsorption. After flushing, 
the renal vessels are transected, and the Fogarty is blocked in the renal artery lumen 
with inflating the balloon with 0.5–1 cc. The kidney is now continuously flushed 
at a low flow rate with the intention of intravascular cooling but preventing lower-
ing body temperature by excessive flushing. Effective flushing can be confirmed 
continuously by looking for renal vein effluent. The kidney is repositioned from 
flank to pelvis, and the robot is redocked for table repositioning.
Figure 17. 
Trocar and patient positioning for RAKAT intracorporeal technique Xi. No use of GelPOINT® device. 
Nephrectomy phase: patient positioned in lateral decubitus; camera trocar supra-umbilical, three 8 mm robot 
trocars in hemiabdomen, AirSeal trocar as assistant trocar infra-umbilical. Transplantation phase: robot 
undocked, table repositioned rather than the patient, and robot redocked (side-docking next to left leg); three 
8 mm robotic trocars in the lower abdomen, reusing 1 former caudal robot trocar site and AirSeal trocar site; 
AirSeal in flank position reusing former robot trocar site; assistant trocar subcostal reusing former robot trocar site.
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4.2.2.4 Transplantation phase
The venous anastomosis is performed in the same way as for the extracorporeal 
technique. Flushing (and graft cooling) through the renal artery is continued until the 
venous anastomosis is complete. The Fogarty is removed, and the arterial anastomosis 
is performed, resulting in only 10––15 min of rewarming time. With the intracorporeal 
technique, the kidney is usually transplanted to the ipsilateral iliac fossa.
4.2.3 Results
Decaestecker et al. published their initial experience on 7 patients [53], updated 
their results of the first 10 cases at EAU 2019 congress [54], and now performed 
15 cases, making this the largest reported series worldwide. Thirteen cases were 
performed extracorporeally and two intracorporeally. Ureteral stricture disease was 
the main indication (12/15). All 15 RAKATs were successfully completed without 
intraoperative complications needing open conversion. Compared to pre-op, there 
was a significant decrease in mean serum creatinine (p = 0.027) and a nonsignifi-
cant increase of mean overall and autotransplant GFR estimated by nuclear DMSA 
and Cr-EDTA scans at 3 months post-op. All patients were free from indwelling 
catheters or nephrostomy tube, recurrent urinary tract infections, debilitating stent 
symptoms, flank pain, or macroscopic hematuria at the last follow-up. Short hos-
pital stay and early recovery confirmed the minimal invasiveness of the approach 
although 3/15 patients experienced a high-grade complication (pulmonary embo-
lism, wound dehiscence, and lower limb compartment syndrome without lasting 
disability). Of note is that the high-grade complications occurred in former cancer 
patients that had the combination of multiple surgeries and radiotherapy.
5. Learning curve and training
The learning curve for RAKT can be relatively short for surgeons experienced in 
robotic surgery and kidney transplant surgery [25, 26]. It cannot be stressed enough 
that a high level of robotic experience is recommended before starting this kind of 
high-stake surgery. Training the technique on dry and wet lab models is mandatory. 
The structured RAKT course provided at ORSI Academy [32] is recommended 
as well as an experienced RAKT proctor supporting first cases. In this way a safe 
introduction of this new technique is possible.
6. Conclusions
RAKT has been proven to be an advanced application for KT. The technique 
is now standardized, and surgical data show that RAKT is safe, feasible, and 
reproducible when performed by surgeons with experience in both robotic and 
KT surgery. Most experience has been gained with grafts from living donors, but 
RAKT from deceased donors is feasible taking into account careful selection and 
optimizing logistics. Finally, RAKAT is an extension of the RAKT technique and is 
a minimal invasive way to salvage kidneys with complex renal, vascular, or ureteral 
pathology, which cannot be treated with conventional in situ techniques. Although 
the ultimate goal could be intracorporeal RAKAT, the extracorporeal technique is 
more versatile for complex cases. Training and proctoring are key to safely intro-
duce this advanced robotic technique and give the transplant patient population the 
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